Cargando…
Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma
BACKGROUND: Platelet derived growth factor receptor (PDGFR) activity is deregulated in human GBM due to amplification and rearrangement of the PDGFR-alpha gene locus or overexpression of the PDGF ligand, resulting in the activation of downstream kinases such as phosphatidylinositol 3-kinase (PI3K),...
Autores principales: | Pitter, Kenneth L., Galbán, Craig J., Galbán, Stefanie, Saeed-Tehrani, Omid, Li, Fei, Charles, Nikki, Bradbury, Michelle S., Becher, Oren J., Chenevert, Thomas L., Rehemtulla, Alnawaz, Ross, Brian D., Holland, Eric C., Hambardzumyan, Dolores |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022633/ https://www.ncbi.nlm.nih.gov/pubmed/21267448 http://dx.doi.org/10.1371/journal.pone.0014545 |
Ejemplares similares
-
Correction: Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma
por: Pitter, Kenneth L., et al.
Publicado: (2011) -
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779
por: Messina, Michael P, et al.
Publicado: (2007) -
The Rapalogue, CCI-779, Improves Salivary Gland Function following Radiation
por: Morgan-Bathke, Maria, et al.
Publicado: (2014) -
Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
por: Lemasson, Benjamin, et al.
Publicado: (2016) -
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
por: Galbán, Stefanie, et al.
Publicado: (2012)